289 related articles for article (PubMed ID: 18981156)
41. Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: the role of NF-kappaB and PPARalpha.
Zapolska-Downar D; Siennicka A; Kaczmarczyk M; Kołodziej B; Naruszewicz M
J Nutr Biochem; 2004 Apr; 15(4):220-8. PubMed ID: 15068815
[TBL] [Abstract][Full Text] [Related]
42. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
[TBL] [Abstract][Full Text] [Related]
43. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules.
Lee JH; Zhou HY; Cho SY; Kim YS; Lee YS; Jeong CS
Arch Pharm Res; 2007 Oct; 30(10):1318-27. PubMed ID: 18038911
[TBL] [Abstract][Full Text] [Related]
45. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice.
Bolick DT; Srinivasan S; Kim KW; Hatley ME; Clemens JJ; Whetzel A; Ferger N; Macdonald TL; Davis MD; Tsao PS; Lynch KR; Hedrick CC
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):976-81. PubMed ID: 15761190
[TBL] [Abstract][Full Text] [Related]
47. Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.
Velagapudi S; Wang D; Poti F; Feuerborn R; Robert J; Schlumpf E; Yalcinkaya M; Panteloglou G; Potapenko A; Simoni M; Rohrer L; Nofer JR; von Eckardstein A
Cardiovasc Res; 2024 Apr; 120(5):476-489. PubMed ID: 38109696
[TBL] [Abstract][Full Text] [Related]
48. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
Matsuo Y; Miura S; Kawamura A; Uehara Y; Rye KA; Saku K
Atherosclerosis; 2007 Sep; 194(1):159-68. PubMed ID: 17118370
[TBL] [Abstract][Full Text] [Related]
49. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner.
Li XA; Titlow WB; Jackson BA; Giltiay N; Nikolova-Karakashian M; Uittenbogaard A; Smart EJ
J Biol Chem; 2002 Mar; 277(13):11058-63. PubMed ID: 11792700
[TBL] [Abstract][Full Text] [Related]
50. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension.
Yogi A; Callera GE; Aranha AB; Antunes TT; Graham D; McBride M; Dominiczak A; Touyz RM
Hypertension; 2011 Apr; 57(4):809-18. PubMed ID: 21383307
[TBL] [Abstract][Full Text] [Related]
51. Possible Involvement of Sphingosine-1-Phosphate/G(i)/RhoA pathways in adherence of eosinophils to pulmonary endothelium.
Sashio T; Kume H; Takeda N; Asano T; Tsuji S; Kondo M; Hasegawa Y; Shimokata K
Allergol Int; 2012 Jun; 61(2):283-93. PubMed ID: 22361510
[TBL] [Abstract][Full Text] [Related]
52. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3).
Aoki S; Yatomi Y; Shimosawa T; Yamashita H; Kitayama J; Tsuno NH; Takahashi K; Ozaki Y
J Thromb Haemost; 2007 Jun; 5(6):1292-301. PubMed ID: 17403093
[TBL] [Abstract][Full Text] [Related]
53. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
54. Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells.
Landsberger M; Wolff B; Jantzen F; Rosenstengel C; Vogelgesang D; Staudt A; Dahm JB; Felix SB
Atherosclerosis; 2007 Jan; 190(1):43-52. PubMed ID: 16529752
[TBL] [Abstract][Full Text] [Related]
55. Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells.
Rossi J; Rouleau L; Emmott A; Tardif JC; Leask RL
Eur J Pharmacol; 2010 Dec; 649(1-3):268-76. PubMed ID: 20863785
[TBL] [Abstract][Full Text] [Related]
56. Ligand-dependent interactions between SR-B1 and S1PR1 in macrophages and atherosclerotic plaques.
Bassila C; Kluck GEG; Thyagarajan N; Chathely KM; Gonzalez L; Trigatti BL
J Lipid Res; 2024 May; 65(5):100541. PubMed ID: 38583587
[TBL] [Abstract][Full Text] [Related]
57. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I.
Seetharam D; Mineo C; Gormley AK; Gibson LL; Vongpatanasin W; Chambliss KL; Hahner LD; Cummings ML; Kitchens RL; Marcel YL; Rader DJ; Shaul PW
Circ Res; 2006 Jan; 98(1):63-72. PubMed ID: 16339487
[TBL] [Abstract][Full Text] [Related]
58. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.
Assanasen C; Mineo C; Seetharam D; Yuhanna IS; Marcel YL; Connelly MA; Williams DL; de la Llera-Moya M; Shaul PW; Silver DL
J Clin Invest; 2005 Apr; 115(4):969-77. PubMed ID: 15841181
[TBL] [Abstract][Full Text] [Related]
59. Follicular fluid high-density lipoprotein-associated sphingosine 1-phosphate (S1P) promotes human granulosa lutein cell migration via S1P receptor type 3 and small G-protein RAC1.
Becker S; von Otte S; Robenek H; Diedrich K; Nofer JR
Biol Reprod; 2011 Mar; 84(3):604-12. PubMed ID: 20980685
[TBL] [Abstract][Full Text] [Related]
60. Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3.
Whetzel AM; Bolick DT; Hedrick CC
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C339-45. PubMed ID: 19091959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
